JPWO2021181159A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021181159A5
JPWO2021181159A5 JP2022554288A JP2022554288A JPWO2021181159A5 JP WO2021181159 A5 JPWO2021181159 A5 JP WO2021181159A5 JP 2022554288 A JP2022554288 A JP 2022554288A JP 2022554288 A JP2022554288 A JP 2022554288A JP WO2021181159 A5 JPWO2021181159 A5 JP WO2021181159A5
Authority
JP
Japan
Prior art keywords
tetrafluoro
trifluoromethylbenzylamino
composition
use according
benzoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022554288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023517566A5 (https=
JP2023517566A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000136 external-priority patent/WO2021181159A1/en
Publication of JP2023517566A publication Critical patent/JP2023517566A/ja
Publication of JP2023517566A5 publication Critical patent/JP2023517566A5/ja
Publication of JPWO2021181159A5 publication Critical patent/JPWO2021181159A5/ja
Pending legal-status Critical Current

Links

JP2022554288A 2020-03-11 2021-03-10 再開通療法後の再灌流傷害又は出血を処置するための組成物及び方法 Pending JP2023517566A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062988187P 2020-03-11 2020-03-11
US62/988,187 2020-03-11
PCT/IB2021/000136 WO2021181159A1 (en) 2020-03-11 2021-03-10 Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy

Publications (3)

Publication Number Publication Date
JP2023517566A JP2023517566A (ja) 2023-04-26
JP2023517566A5 JP2023517566A5 (https=) 2024-03-19
JPWO2021181159A5 true JPWO2021181159A5 (https=) 2024-03-19

Family

ID=77665492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554288A Pending JP2023517566A (ja) 2020-03-11 2021-03-10 再開通療法後の再灌流傷害又は出血を処置するための組成物及び方法

Country Status (12)

Country Link
US (3) US11826329B2 (https=)
EP (1) EP4117648A4 (https=)
JP (1) JP2023517566A (https=)
KR (1) KR20230010187A (https=)
CN (1) CN115515573A (https=)
AU (1) AU2021233206A1 (https=)
BR (1) BR112022018136A2 (https=)
CA (1) CA3174709A1 (https=)
CO (1) CO2022014343A2 (https=)
IL (2) IL296288B2 (https=)
MX (2) MX2022011214A (https=)
WO (1) WO2021181159A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12285182B2 (en) 2018-10-10 2025-04-29 Innova Vascular, Inc. Devices and methods for removing an embolus
AU2021233206A1 (en) 2020-03-11 2022-10-06 Gnt Pharma Co., Ltd. Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy
CN113995723B (zh) * 2020-07-27 2025-02-18 浙江普洛家园药业有限公司 一种索法地尔冻干粉针剂的制备方法及其产品和用途
KR20240142433A (ko) * 2021-12-28 2024-09-30 주식회사 지엔티파마 폐 장애를 치료하기 위한 조성물 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1309703C (zh) * 2002-06-19 2007-04-11 纽若泰克有限公司 四氟苄基衍生物及含有其成分的用于治疗和预防中枢神经系统的急慢性神经变性疾病的药物组合物
KR100522188B1 (ko) * 2003-01-20 2005-10-18 주식회사 뉴로테크 뉴로트로핀에 의해 유도되는 세포괴사 억제 방법
WO2006126825A1 (en) 2005-05-23 2006-11-30 Choongwae Pharma Corporation Composition comprising tetrafluorobenzyl derivatives or salts of thereof for injection
CN101180263B (zh) 2005-05-25 2011-11-02 株式会社中外制药 取代四氟苄基苯胺化合物及其药学可接受的盐的制备方法
KR101523345B1 (ko) 2008-04-28 2015-05-28 주식회사 지엔티파마 재관류 손상의 치료 또는 예방용 약학 조성물
CN102617383A (zh) 2012-03-20 2012-08-01 横店集团家园化工有限公司 索法地尔晶型、制备方法及包含索法地尔晶体的无菌粉末
JP2018502894A (ja) 2015-01-27 2018-02-01 アストラゼネカ アクチボラグ 心筋梗塞の病歴がある患者においてアテローム血栓性イベントを治療または予防する方法
AU2021233206A1 (en) 2020-03-11 2022-10-06 Gnt Pharma Co., Ltd. Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy

Similar Documents

Publication Publication Date Title
Tanaka et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee
Gordon-Smith et al. Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep-vein thrombosis
US9044452B2 (en) Use of resiniferatoxin (RTX) for producing an agent for treating joint pains and method for applying said agent
JP5213137B2 (ja) 中程度の持続時間の神経筋遮断剤およびそのアンタゴニスト
JP2021514382A (ja) デオキシコール酸を含む医薬組成物
WO2000040086A1 (en) Formulations for treating disease and methods of using same
KR970005837B1 (ko) 조직 플라스미노겐 활성화제(t-PA) 활성을 갖는 고농도 단백질 용액의 제조방법, t-PA 활성을 갖는 단백질 용액, 및 이러한 용액을 포함하는 섬유소 용해성 조성물
JP2021536502A (ja) アミノ酸ベースの栄養素の使用及びそれを含む医薬組成物
EP4117648A1 (en) Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy
US4944943A (en) Mixture of a substance having thrombolytic activity and of an antithrombotic substance
CN108697673A (zh) 用于治疗莫顿神经瘤疼痛的辣椒碱依次给予方法
JP2002534477A (ja) メラガトランの新規使用
JPWO2021181159A5 (https=)
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
US20230414617A1 (en) Pharmaceutical composition comprising acid-base neutralization combination and application thereof
Tsapogas The role of fibrinolysis in the treatment of arterial thrombosis: Experimental and clinical aspects
CA2766533A1 (en) Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
JPS6150927B2 (https=)
CA2242364A1 (en) Combination injection preparation
US3790672A (en) Method for activating blood fibrinolysis by administration of a salt of 2-amino-ethanesulphonic acid
KR20240117782A (ko) 켈로이드 치료를 위한 피부 패치와 주사 치료제 조성물
KR20190117318A (ko) 우수한 안정성을 갖는 데옥시콜린산 함유 주사제 조성물 및 이의 제조방법
US20190365730A1 (en) Anaesthetic composition comprising ropivacaine, prilocaine and lidocaine
HU207455B (en) Method for producing pharmaceutical preparations suitable for treating postischemical heart-troubles containing captoprile and in given case thrombolitic agent
JPH03505447A (ja) アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物